EN
Breast cancer is the commonest cancer diagnosis in women, and that is exactly why there is so much confusion around it. One doctor says one thing, another says something else, and the internet is frightening. The German approach starts not with treatment but with putting a clear picture in your hands: what kind of tumour this is, how it is built and what plan makes sense for it. Everything else depends on how precisely the first question is answered.
How people usually arrive
In different ways. One woman has felt a lump herself, another has been referred after a routine examination, a third has already had surgery at home and wants to know whether everything was done correctly. German breast medicine does not sort patients into “simple” and “complex” cases in advance — the particular situation is worked through first, and only then are the steps discussed.
First the diagnosis is confirmed
Breast assessment in Germany is built around familiar methods: mammography, ultrasound and, where needed, MRI. The country has an early detection programme — mammography is offered free to women between 50 and 75 every two years, and most cases fall in that age range. But an image is only the beginning of the conversation.
The decisive step is a biopsy and examination of the tissue itself. From a piece of the tumour the pathologist establishes not only whether it is malignant but its character: whether it is sensitive to the female hormones oestrogen and progesterone, and whether its cells carry the HER2 protein, which makes a tumour grow faster. These details are not a formality. Which treatment will work on your particular tumour, and which will be useless, depends directly on them. In effect, no honest plan can be made before that analysis.
How the treatment is chosen
The decision is taken not by one doctor but by a board — oncologist, surgeon, radiation oncologist and pathologist look at the case together. That format is the norm in German hospitals rather than the exception, and it reduces the risk of something being missed. The main approaches are well known, and they are combined for the particular situation.
Surgery today is increasingly conservative. With an early tumour the aim is to keep the breast, removing only the affected area rather than the whole gland; where removal is unavoidable, reconstruction is discussed — immediately or later. Radiotherapy is usually given after breast-conserving surgery, to reduce the risk of the disease returning in the same place.
Drug treatment is chosen by the character of the tumour established at biopsy. If the tumour depends on hormones, hormone therapy is given to cut off that supply. If the cells carry the HER2 protein, targeted drugs aimed precisely at that mark are used. Chemotherapy is not always used, only where it is genuinely needed, and increasingly special tissue tests help make that decision. The point is not to treat “just in case” but to strike precisely.
When there are doubts — a second opinion
If the diagnosis has already been made at home but questions remain, it is sensible to start not with a suitcase but with a second opinion. A German specialist studies your images, the biopsy slides and the reports, and says whether they confirm the diagnosis and agree with the proposed plan. Sometimes that spares an unnecessary intervention; sometimes it opens a gentler option that was never mentioned at home. Either way you get something to stand on rather than one more contradictory opinion.
This material is for information only and does not replace a consultation with a doctor. Whether treatment is possible, what it will involve and what it will achieve can be determined only after an examination at the clinic in person.